FDA Raises Concerns Over Children's COVID-19 Vaccine Safety
An internal memo from the U.S. Food and Drug Administration suggests that COVID-19 vaccinations may have led to the deaths of at least 10 children. The memo, citing myocarditis as a potential cause, was reported by the New York Times. Reuters has yet to verify these claims.
The U.S. Food and Drug Administration (FDA) expressed concerns in an internal memo about the safety of COVID-19 vaccinations for children. The memo indicated that at least 10 pediatric deaths might be linked to the vaccinations, with myocarditis listed as a possible cause, according to a report by the New York Times.
Despite the gravity of the information, Reuters has been unable to independently verify the accuracy of the FDA's claims, leaving questions about the true extent of the vaccine's side effects on children.
This development comes amidst ongoing debates over the safety and necessity of vaccinating children against COVID-19, highlighting the balancing act between public health measures and individual safety concerns.
(With inputs from agencies.)
- READ MORE ON:
- FDA
- children
- vaccine
- deaths
- New York Times
- myocarditis
- COVID-19
- Reuters
- safety
- public health
ALSO READ
Belgian Court Orders Poland and Romania to Accept €1.9 Billion COVID-19 Vaccine Delivery
WHO Signals Critical Data Push Ahead of May 2026 COVID-19 Vaccine Update Decision
During supply chain disruption in COVID-19 pandemic, we decided India would become hub of semiconductor manufacturing: PM Modi.
Pfizer and BioNTech Pause COVID-19 Vaccine Trial Due to Low Enrollment
Belgian Court Mandates Poland and Romania to Accept COVID-19 Vaccine Deliveries

